Pregabalin and Eye discharge - a phase IV clinical study of FDA data

Summary:

Eye discharge is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 60+ old, also take Calcium, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Eye discharge when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Eye discharge?

Eye discharge is found to be associated with 687 drugs and 805 conditions by eHealthMe. Check the latest studies of Eye discharge.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 17 people (0.02%) have Eye discharge.

Among these 17 people:

What is the gender of people who have Eye discharge when taking Pregabalin? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Eye discharge when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

What are other side effects people have besides Eye discharge? *

Fatigue (feeling of tiredness): 9 people, 52.94%
Headache (pain in head): 7 people, 41.18%
Rhinorrhea (watery mucus discharge from the nose): 7 people, 41.18%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 41.18%
Diarrhea: 7 people, 41.18%
Eye Irritation: 6 people, 35.29%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 29.41%
Hot Flush (sudden feelings of heat): 5 people, 29.41%
Onychomadesis (a periodic idiopathic shedding of the nails): 5 people, 29.41%
Fever: 5 people, 29.41%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 41.18%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 11.76%
Osteomyelitis (infection of bone): 2 people, 11.76%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 11.76%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 5.88%
Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Eye discharge?

- Check whether Eye discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,070 reports)

Eye discharge treatments and more:

Eye discharge (10,525 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye discharge:

Eye discharge (687 drugs)

Browse all the conditions that are associated with Eye discharge:

Eye discharge (805 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.